Details

NameSymbolSector
JOHNSON PHARMACARE LIMITEDJOHNPHARMADiversified Commercial Services
Open
0.77
High
0.77
Low
0.75
Close
0.75
Volume
936947
Exchange
bse
Time
03-Oct-2025

Outlook

Score:  

1.75

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Johnson Pharmacare is  
Marubozu
Estimated Stoploss of Johnson Pharmacare is ₹  
0.77
Johnson Pharmacare has a  
Bearishℹ
 pattern. 
Formation of  
Marubozu
 candle pattern indicates Johnson Pharmacare has chances of  
Continuationℹ
 of the current trend. 

Trend

Johnson Pharmacare is in  
Sideways trendℹ
. 
Price of Johnson Pharmacare is  
Downℹ
 by  

9.64

%. 
Target
Buy @ 

0.72

Sell @ 

0.88

Current @ 

0.75

Volume

The trade volumes of Johnson Pharmacare have been  
Underperformingℹ
The volume trend for Johnson Pharmacare is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Johnson Pharmacare is  

Down

 by  

8.65

% 

Valuation

The current market price of Johnson Pharmacare is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 57cr and total assets worth ₹ 57cr, the balance sheet of Johnson Pharmacare is:  
Balancedℹ
. 
Cashflow
Johnson Pharmacare has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

20% i.e. ₹ 1cr spent in operatingℹ
60% i.e. ₹ 3cr earned in investingℹ
20% i.e. ₹ 1cr spent in financingℹ
0% in otherℹ
Income
The income of Johnson Pharmacare is  

₹ 0cr

 and  

Loss

 is :  

₹ 0cr

(*Jun 2025)

Johnson Pharmacare Losses increased by:  

0

% and Income is Up by:  

0

% 

(*Jun 2025)

The income of Johnson Pharmacare is  

₹ 0cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Johnson Pharmacare Losses increased by:  

0

% and Income is Up by:  

0

% 

(*Mar 2025)

The income of Johnson Pharmacare is  

₹ 0cr

 and  

Loss

 is :  

₹ 0cr

(*Dec 2024)

Johnson Pharmacare Losses increased by:  

0

% and Income is Up by:  

0

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.